Clinical Genomics and Quest Diagnostics extend collaboration to provide InSure® ONE™, a fecal immunochemical test for colorectal cancer screening programs
November 01, 2018 08:18 ET
|
Clinical Genomics
Relationship ensures broad access to innovative FIT test in the U.S. BRIDGEWATER, N.J., and SECAUCUS, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading innovator of tests for...
South Jersey women raises $2.5 million over 10 years in the memory of her father and grandfather, both lost to colon cancer
November 01, 2018 07:10 ET
|
Colon Cancer Coalition
PHILADELPHIA, Penn. / MINNEAPOLIS, Minn., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Get Your Rear in Gear – Philadelphia started in 2009 as grief therapy for a Mount Laurel, NJ resident. To combat the...
STOLEN COLON TO BE REPLACED
October 29, 2018 08:15 ET
|
Colon Cancer Coalition
Minneapolis, Minn. / Kansas City, Mo., Oct. 29, 2018 (GLOBE NEWSWIRE) -- The missing inflatable colon that has captured attention across the globe has not been recovered, but there is good news. The...
Delårsrapport januari-september 2018
October 23, 2018 02:00 ET
|
PledPharma AB
SAMMANDRAG JULI-SEPTEMBER I KORTHET PledPharma redovisar positiva slutresultat från klinisk proof of principle-studie av Aladote®Det vetenskapliga rådet för Aladote® har haft sitt första...
Interim Report January-September 2018
October 23, 2018 02:00 ET
|
PledPharma AB
Summary JULY-SEPTEMBER IN BRIEF PledPharma announces positive results from the Aladote® proof of principle studyThe Scientific Advisory Board for Aladote® held its first meeting with focus...
Studieläkemedel till PledPharmas globala fas III program med läkemedelskandidaten PledOx® levererat
September 28, 2018 02:00 ET
|
PledPharma AB
Stockholm, 28 september 2018. PledPharma AB (publ) meddelar i dag att studieläkemedlet till det planerade fas III‑programmet med läkemedelskandidaten PledOx® är framgångsrikt färdigproducerat och...
Study drug for the PledOx® global phase III program delivered
September 28, 2018 02:00 ET
|
PledPharma AB
Stockholm, September 28, 2018. PledPharma AB (publ) announces that the PledOx® study drug for the planned phase III program has successfully been produced and delivered. As previously announced,...
Colorectal Cancer Alliance Hires Wendy Nickel as Vice President of Prevention
September 27, 2018 06:00 ET
|
Colorectal Cancer Alliance
Washington, D.C., Sept. 27, 2018 (GLOBE NEWSWIRE) -- National nonprofit Colorectal Cancer Alliance (Alliance) has welcomed Wendy Nickel as its vice president of prevention. Nickel’s primary...
PledPharma förväntar sig leverans av studieläkemedel till fas III-programmet med PledOx® i september
August 15, 2018 02:00 ET
|
PledPharma AB
Stockholm, 15 augusti 2018. PledPharma AB (publ) meddelar idag att studieläkemedel till det planerade fas III-programmet med läkemedelskandidaten PledOx® förväntas kunna levereras under september...
Delivery of study drug to the PledOx® phase III program is expected in September
August 15, 2018 02:00 ET
|
PledPharma AB
Stockholm, August 15, 2018. PledPharma AB (publ) announces today that delivery of PledOx® study drug for the planned phase III program is expected during September 2018. As previously announced,...